Specialities and Expertise:Influenza Vaccines Development, Protein-based Therapeutics, Plant-based Proficia Technology, Virus-Like Particles (VLP) Technology, Influenza VLP Vaccine, Monoclonal Antibody Production, Antibody Glycoengineering, Pandemic Flu Development, Seasonal Influenza Vaccines, Vaccine Discovery, Antibody Discovery, Immunotherapy, Rotavirus Vaccine Development, Norovirus Preclinical, Coronavirus Preclinical, Quadrivalent VLP Influenza Vaccine, Coronavirus Vaccine Candidates, Coronavirus Antibody Candidates, Virus-Like Particle (VLPs) Coronavirus, Coronavirus Candidates Preclinical, Quadrivalent Influenza Vaccine.
Size and Minority Status
- Products and services 1
- Сommodity codes
Medicago's plant-based Proficia technology uses transient protein expression in plant leaves for producing virus-like particles (VLPs) and therapeutic proteins.
External Recognition 1
Locations Served 1
Public Spend Forum compiles the information shown in GovShop's supplier profiles based on multiple sources and relies on GovShop's supplier and buyer user community to help validate the information. We recommend conducting further due diligence and research to validate the information if accuracy is critical.